Cyclopharm Ltd is an Australian medical technology company that develops and supplies products for nuclear medicine imaging. Its main product, Technegas, is a carbon-based aerosol that patients inhale so that clinicians can take pictures of lung ventilation and assess how well the lungs are working. The company serves hospitals and nuclear medicine departments, and its technology is used in the diagnosis of lung conditions such as pulmonary embolism. Cyclopharm is based in Australia.
The shares are listed on the Australian Securities Exchange in Australia under the code CYC, and the price on this page is in Australian dollars (AUD). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Weak price profile
Ranks #1478 of 1815 on the Australian Securities Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for Australia yet.
TrendWeak
14/100
Below its long-term averages and far from its highs.
See the numbers →
Above 200-day average-44.6%
From 52-week high-69.9%
MomentumWeak
22/100
Lagging most stocks on this exchange.
See the numbers →
3-month return-33.9%
6-month return-48.6%
12-month, skipping last month-26.7%
Stability (higher is calmer)Weak
34/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)79.6%
Worst drawdown, 1 year (smaller is calmer)-69.9%
LiquidityWeak
48/100
Thinly traded: prices can jump and exits can be hard.
See the numbers →
Avg daily value traded0.03M AUD
Zero-volume days1.7%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends2
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for Australia when fundamentals data for this market is added. All Australia stocks.
52-wk range 0.370 – 1.290Daily closes, split-adjusted
Signals
50-day average0.478
200-day average0.668
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.023
Technical summary
Daily
Bearish
4 bullish · 0 neutral · 12 bearish
Weekly
Strongly bearish
0 bullish · 1 neutral · 11 bearish
Monthly
Strongly bearish
0 bullish · 1 neutral · 7 bearish
Moving averages (daily)
SMA 10
0.43
Bearish
EMA 10
0.42
Bearish
SMA 20
0.44
Bearish
EMA 20
0.44
Bearish
SMA 50
0.48
Bearish
EMA 50
0.48
Bearish
SMA 100
0.51
Bearish
EMA 100
0.53
Bearish
SMA 200
0.67
Bearish
EMA 200
0.64
Bearish
Oscillators (daily)
RSI (14)
29.77
Bullish
MACD (12, 26)
-0.02
Bearish
Momentum (12)
-16.85
Bearish
Stochastic %K (14)
0.00
Bullish
Williams %R (14)
-100.0
Bullish
CCI (20)
-217.1
Bullish
Pivot points (classic, last session)
S3
0.35
S2
0.36
S1
0.37
Pivot
0.38
R1
0.38
R2
0.39
R3
0.40
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Dividends
Paid, last 12 months
0.00 AUD
Yield on today's price
–
Frequency
None in the last year
Next ex-dividend date
Not announced
Ex-dividend date
Amount per share
0.0050
0.0050
0.0050
0.0050
0.0050
0.0050
0.0050
0.0050
0.0050
0.0050
Ex-dividend dates and amounts from EODHD. Shown as declared, before tax.
Prices are end-of-day closes in AUD. Educational only, not financial advice.
